AFLD 2014 FFBad vs Respondent M05

Facts
The French Badminton Federation (Fédération Française de Badminton, FFBad) charges respondent M05 for a violation of the Anti-Doping Rules. During an event on May 19, 2013, a sample was taken for doping test purposes. The analysis of the sample showed the presence of prednisolone and prednisone. These substances are prohibited according the World Anti-Doping Agency (WADA) prohibited list and regarded as specified substances.

History
The respondent used medication containing prednisolone which metabolizes into prednisolone to treat a pain in the knee. This was mentioned on the doping control form. He has a prescription and
two certificats from his physician.
The panel regards the measured concentrations consistent with the medical use of the prohibited substances.

Decision
1. The respondent is acquitted.
2. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
23 January 2014
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Sport/IFs
Badminton (BWF) - Badminton World Federation
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Badminton (FFBad) - The French Badminton Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S9. Glucocorticosteroids
Substances
Prednisolone
Prednisone
Medical terms
Legitimate Medical Treatment
Physical injury
Document type
Pdf file
Date generated
6 August 2014
Date of last modification
25 September 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin